In the vast majority of cases of Parkinson’s disease, or “shaking palsy,” physicians cannot be sure what originally caused the nerve damage that results in the patient’s tremor, muscle rigidity, ...

A drug already used safely to treat Parkinson's disease, restless leg syndrome and other movement disorders also could delay or prevent the most common cause of blindness affecting more than 9 million ...

Researchers have discovered why long-term use of L-DOPA (levodopa), the most effective treatment for Parkinson's disease, commonly leads to a movement problem called dyskinesia, a side effect that can ...

The U.S. Food and Drug Administration has given approval for the drug Stalevo-a cocktail of levodopa (L-dopa), carbidopa, and entacapone-to be marketed in the United States for the treatment of ...

A team of scientists led by Cathie Martin, PhD, professor at the department of metabolic biology and biological chemistry at the John Innes Centre, U.K., has engineered tomatoes to act as an enriched ...

Parkinson’s patients who take the drug levodopa, or L-Dopa, are inevitably disappointed. At first, during a “honeymoon” period, their symptoms (which include tremors and balance problems) are brought ...

A team of University of California, Irvine researchers has discovered a possible reason why L-dopa, the front-line drug for treating Parkinson's disease, loses efficacy and causes ...

A team of researchers has reported progress in testing a new approach involving the dopamine system that they hope may help reduce symptoms of post-traumatic stress disorder (PTSD). Led by 2014 BBRF ...